| Elizabeth H Binney, MD | |
|
486 Boston Post Rd, Weston, MA 02493-1529 | |
| (781) 899-4456 | |
| Not Available |
| Full Name | Elizabeth H Binney |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 486 Boston Post Rd, Weston, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750338406 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 154576 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth H Binney, MD 486 Boston Post Rd, Weston, MA 02493-1529 Ph: (781) 899-4456 | Elizabeth H Binney, MD 486 Boston Post Rd, Weston, MA 02493-1529 Ph: (781) 899-4456 |
News Archive
In academia, the discipline of communication has changed significantly, according to University of Missouri-Columbia researchers.
Roboticists are envisioning a future in which soft, animal-inspired robots could be safely deployed in difficult-to-access natural and man-made environments, such as in delicate surgical procedures in the human body, or in spaces too small and unpredictable to be conquered with rigid robots or too dangerous for humans to work with rigid robots in.
Inspiration Biopharmaceuticals, Inc. today reported data from its ongoing Phase 2/3 study evaluating the efficacy of OBI-1, an investigational recombinant porcine factor VIII (FVIII), for the treatment of serious bleeds in people with acquired hemophilia A. According to the interim analysis, seven out of seven trial participants receiving OBI-1 experienced control and subsequent resolution of their bleeds.
Columbia University biologists have revealed a mechanism by which bacterial cells in crowded, oxygen-deprived environments access oxygen for energy production, ensuring survival of the cell. The finding could explain how some bacteria, such as Pseudomonas aeruginosa (P. aeruginosa), are able to thrive in oxygen-poor environments like biofilms and resist antibiotics.
The ALS Therapy Development Institute today announced a research agreement with Biogen Idec and UCB Pharma SA to investigate the use of an anti-CD40L antibody as a potential therapy for Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's or Motor Neuron Disease.
› Verified 7 days ago
Dr. Robert H. Andler, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 486 Boston Post Road, Weston, MA 02693 Phone: 781-899-4456 Fax: 781-647-9578 | |
Dr. Rosemarie Dieffenbach, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 486 Boston Post Road, Weston, MA 02493 Phone: 781-899-4456 Fax: 781-647-9578 | |
Dr. Gail K Kraft, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 30 Holly Cir, Weston, MA 02493 Phone: 781-235-0560 Fax: 781-235-4345 | |
Dr. Jennifer R Kim, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9 Riverside Rd, Health Advances, Llc, Weston, MA 02493 Phone: 781-647-3435 | |
Kristi Rae Monica, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 486 Boston Post Rd, Weston, MA 02493 Phone: 781-899-4456 | |
David L Maltz, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 215 Highland St, Weston, MA 02493 Phone: 781-943-2202 | |
Mrs. Margaret Manion, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 486 Boston Post Rd, Weston, MA 02493 Phone: 781-899-4456 Fax: 781-647-8905 |